Medidata Solutions Inc (NASDAQ:MDSO) Expected to Announce Quarterly Sales of $189.93 Million
Wall Street analysts forecast that Medidata Solutions Inc (NASDAQ:MDSO) will report $189.93 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Medidata Solutions’ earnings, with the highest sales estimate coming in at $192.30 million and the lowest estimate coming in at $187.86 million. Medidata Solutions posted sales of $163.41 million during the same quarter last year, which would indicate a positive year over year growth rate of 16.2%. The firm is expected to report its next quarterly earnings results on Thursday, October 17th.
According to Zacks, analysts expect that Medidata Solutions will report full-year sales of $739.93 million for the current year, with estimates ranging from $737.50 million to $741.60 million. For the next financial year, analysts expect that the firm will report sales of $851.16 million, with estimates ranging from $835.64 million to $865.65 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Monday, July 22nd. The company reported $0.48 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.31. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The firm had revenue of $180.50 million for the quarter, compared to analyst estimates of $179.95 million. During the same quarter in the prior year, the firm earned $0.43 EPS. The company’s revenue was up 15.8% on a year-over-year basis.
Medidata Solutions stock traded down $0.02 during trading hours on Friday, reaching $91.62. 36,331 shares of the company’s stock traded hands, compared to its average volume of 797,390. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.56 and a current ratio of 2.56. Medidata Solutions has a fifty-two week low of $60.10 and a fifty-two week high of $98.60. The firm has a market capitalization of $5.72 billion, a price-to-earnings ratio of 95.46, a PEG ratio of 6.91 and a beta of 1.22. The firm’s 50 day moving average is $91.60 and its 200-day moving average is $88.74.
Several large investors have recently made changes to their positions in MDSO. Municipal Employees Retirement System of Michigan raised its holdings in Medidata Solutions by 1.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 11,510 shares of the company’s stock worth $1,042,000 after buying an additional 120 shares during the period. United Capital Financial Advisers LLC raised its holdings in Medidata Solutions by 0.4% during the 2nd quarter. United Capital Financial Advisers LLC now owns 41,107 shares of the company’s stock worth $3,721,000 after buying an additional 171 shares during the period. Flagship Harbor Advisors LLC raised its holdings in Medidata Solutions by 58.3% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 475 shares of the company’s stock worth $42,000 after buying an additional 175 shares during the period. Zions Bancorporation N.A. grew its stake in shares of Medidata Solutions by 5.9% during the 2nd quarter. Zions Bancorporation N.A. now owns 3,521 shares of the company’s stock worth $319,000 after acquiring an additional 195 shares in the last quarter. Finally, Russell Investments Group Ltd. grew its stake in shares of Medidata Solutions by 0.8% during the 2nd quarter. Russell Investments Group Ltd. now owns 51,056 shares of the company’s stock worth $4,621,000 after acquiring an additional 402 shares in the last quarter. Institutional investors and hedge funds own 91.31% of the company’s stock.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management.
Featured Story: How does inflation affect different investments?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.